Skip to main content

Table 4 p16 expression in endocervical and endometrial adenocarcinomas.

From: Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

  ECA EMMA p-value
0 2 5  
1–10 1 1  
11–50 1 8  
Total score (0–50) 4/14 (29%) 14/18 (78%)  
51–80 3 3  
81–100 7 1  
Total score (51–100) 10/14 (71%) 4/18 (22%) 0.005
Median (Range) 85 (0–100) 30 (0–100) 0.007
  1. ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma.